Advertisement

Nociceptin Receptors in Alcohol Use Disorders: A Positron Emission Tomography Study Using [11C]NOP-1A

      Abstract

      Background

      The neuropeptide transmitter nociceptin, which binds to the nociceptin/orphanin FQ peptide (NOP) receptor, is a core component of the brain's antistress system. Nociceptin exerts its antistress effect by counteracting the functions of corticotropin-releasing factor, the primary stress-mediating neuropeptide in the brain. Basic investigations support a role for medications that target nociceptin receptors in the treatment of alcohol use disorders. Thus, it is of high interest to measure the in vivo status of NOP receptors in individuals with alcohol use disorders.

      Methods

      Here, we used [11C]NOP-1A and positron emission tomography to measure the in vivo binding to NOP receptors in 15 alcohol-dependent humans as identified by DSM-IV and 15 healthy control subjects matched for age, sex, and smoking status. Alcohol-dependent individuals with no comorbid psychiatric, medical, or drug abuse disorders were scanned following 2 weeks of outpatient monitored abstinence (confirmed with three times per week urine alcohol metabolite testing). [11C]NOP-1A distribution volume in regions of interest (including the amygdala, hippocampus, and midbrain, striatal, and prefrontal cortical subdivisions) was measured with kinetic analysis using the arterial input function.

      Results

      Regional [11C]NOP-1A distribution volume in alcohol dependence was not significantly different compared with healthy control subjects. No relationship between [11C]NOP-1A distribution volume and other clinical measures (including duration and severity of alcohol abuse, craving, and anxiety or depressive symptoms) were significant after correction for the multiple hypotheses tested.

      Conclusions

      The results of this study do not support alterations in the binding to NOP receptors in alcohol dependence. However, this finding does not necessarily rule out alterations in nociceptin transmission in alcohol dependence.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Koob G.F.
        Theoretical frameworks and mechanistic aspects of alcohol addiction: Alcohol addiction as a reward deficit disorder.
        Curr Top Behav Neurosci. 2013; 13: 3-30
        • Koob G.F.
        A role for brain stress systems in addiction.
        Neuron. 2008; 59: 11-34
        • Ciccocioppo R.
        • Martin-Fardon R.
        • Weiss F.
        • Massi M.
        Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats.
        Neuroreport. 2001; 12: 1145-1149
        • Cruz M.T.
        • Herman M.A.
        • Kallupi M.
        • Roberto M.
        Nociceptin/orphanin FQ blockade of corticotropin-releasing factor-induced gamma-aminobutyric acid release in central amygdala is enhanced after chronic ethanol exposure.
        Biol Psychiatry. 2012; 71: 666-676
        • Witkin J.M.
        • Statnick M.A.
        • Rorick-Kehn L.M.
        • Pintar J.E.
        • Ansonoff M.
        • Chen Y.
        • et al.
        The biology of nociceptin/orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
        Pharmacol Ther. 2014; 141: 283-299
        • Ciccocioppo R.
        • Panocka I.
        • Polidori C.
        • Regoli D.
        • Massi M.
        Effect of nociceptin on alcohol intake in alcohol-preferring rats.
        Psychopharmacology (Berl). 1999; 141: 220-224
        • Economidou D.
        • Cippitelli A.
        • Stopponi S.
        • Braconi S.
        • Clementi S.
        • Ubaldi M.
        • et al.
        Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat.
        Alcohol Clin Exp Res. 2011; 35: 747-755
        • Ciccocioppo R.
        • Economidou D.
        • Fedeli A.
        • Angeletti S.
        • Weiss F.
        • Heilig M.
        • et al.
        Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats.
        Psychopharmacology (Berl). 2004; 172: 170-178
        • Martin-Fardon R.
        • Ciccocioppo R.
        • Massi M.
        • Weiss F.
        Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats.
        Neuroreport. 2000; 11: 1939-1943
        • Gustafsson L.
        • Ploj K.
        • Nylander I.
        Effects of maternal separation on voluntary ethanol intake and brain peptide systems in female Wistar rats.
        Pharmacol Biochem Behav. 2005; 81: 506-516
        • Economidou D.
        • Hansson A.C.
        • Weiss F.
        • Terasmaa A.
        • Sommer W.H.
        • Cippitelli A.
        • et al.
        Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat.
        Biol Psychiatry. 2008; 64: 211-218
        • Kuzmin A.
        • Bazov I.
        • Sheedy D.
        • Garrick T.
        • Harper C.
        • Bakalkin G.
        Expression of pronociceptin and its receptor is downregulated in the brain of human alcoholics.
        Brain Res. 2009; 1305: S80-S85
        • Pike V.W.
        • Rash K.S.
        • Chen Z.
        • Pedregal C.
        • Statnick M.A.
        • Kimura Y.
        • et al.
        Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography.
        J Med Chem. 2011; 54: 2687-2700
        • Berthele A.
        • Platzer S.
        • Dworzak D.
        • Schadrack J.
        • Mahal B.
        • Buttner A.
        • et al.
        [3H]-nociceptin ligand-binding and nociceptin opioid receptor mRNA expression in the human brain.
        Neuroscience. 2003; 121: 629-640
        • Bridge K.E.
        • Wainwright A.
        • Reilly K.
        • Oliver K.R.
        Autoradiographic localization of (125)i[Tyr(14)] nociceptin/orphanin FQ binding sites in macaque primate CNS.
        Neuroscience. 2003; 118: 513-523
        • Kimura Y.
        • Fujita M.
        • Hong J.
        • Lohith T.G.
        • Gladding R.L.
        • Zoghbi S.S.
        • et al.
        Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors.
        J Nucl Med. 2011; 52: 1638-1645
        • Lohith T.G.
        • Zoghbi S.S.
        • Morse C.L.
        • Araneta M.F.
        • Barth V.N.
        • Goebl N.A.
        • et al.
        Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11C-NOP-1A.
        J Nucl Med. 2012; 53: 385-392
        • Raddad E.
        • Chappell A.
        • Meyer J.
        • Wilson A.
        • Ruegg C.E.
        • Tauscher J.
        • et al.
        Occupancy of nociceptin/orphanin FQ peptide receptors by the antagonist LY2940094 in rats and healthy human subjects.
        Drug Metab Dispos. 2016; 44: 1536-1542
        • Lohith T.G.
        • Zoghbi S.S.
        • Morse C.L.
        • Araneta M.D.
        • Barth V.N.
        • Goebl N.A.
        • et al.
        Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.
        Neuroimage. 2014; 87: 89-95
        • Sullivan J.T.
        • Sykora K.
        • Schneiderman J.
        • Naranjo C.A.
        • Sellers E.M.
        Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).
        Br J Addict. 1989; 84: 1353-1357
        • Selzer M.L.
        The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument.
        Am J Psychiatry. 1976; 127: 1653-1658
        • Skinner H.A.
        • Allen B.A.
        Alcohol dependence syndrome: measurement and validation.
        J Abnorm Psychol. 1982; 91: 199-209
        • Saunders J.B.
        • Aasland O.G.
        • Babor T.F.
        • de la Fuente J.R.
        • Grant M.
        Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption–II.
        Addiction. 1993; 88: 791-804
        • Flannery B.A.
        • Volpicelli J.R.
        • Pettinati H.M.
        Psychometric properties of the Penn Alcohol Craving Scale.
        Alcohol Clin Exp Res. 1999; 23: 1289-1295
        • Fagerstrom K.
        • Heatherton T.F.
        • Koslowski T.
        Nicotine addiction and its assessment.
        Ear Nose Throat J. 1991; 69: 763-765
        • Hamilton M.
        The assessment of anxiety scales by rating.
        Br J Med Psychol. 1959; 32: 50-55
        • Radloff L.S.
        The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adults.
        J Youth Adolesc. 1991; 20: 149-166
        • Hill A.V.
        The possible effects of the aggregation of the molecules of haemoglobin on its disassociation curves.
        Phys Med Biol. 1910; 1991: 749-761
        • Gunn R.N.
        • Sargent P.A.
        • Bench C.J.
        • Rabiner E.A.
        • Osman S.
        • Pike V.W.
        • et al.
        Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET.
        Neuroimage. 1998; 8: 426-440
        • Gandelman M.S.
        • Baldwin R.M.
        • Zoghbi S.S.
        • Zea-Ponce Y.
        • Innis R.B.
        Evaluation of ultrafiltration for the free fraction determination of single photon emission computerized tomography (SPECT) radiotracers: b-CIT, IBF and iomazenil.
        J Pharmaceutical Sci. 1994; 83: 1014-1019
        • Narendran R.
        • Frankle W.G.
        • Mason N.S.
        • Rabiner E.A.
        • Gunn R.N.
        • Searle G.E.
        • et al.
        Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
        Synapse. 2009; 63: 447-461
        • Smith S.M.
        • Jenkinson M.
        • Woolrich M.W.
        • Beckmann C.F.
        • Behrens T.E.
        • Johansen-Berg H.
        • et al.
        Advances in functional and structural MR image analysis and implementation as FSL.
        Neuroimage. 2004; 23: S208-S219
        • Abi-Dargham A.
        • Mawlawi O.
        • Lombardo I.
        • Gil R.
        • Martinez D.
        • Huang Y.
        • et al.
        Prefrontal dopamine D1 receptors and working memory in schizophrenia.
        J Neurosci. 2002; 22: 3708-3719
        • Narendran R.
        • Mason N.S.
        • Laymon C.
        • Lopresti B.
        • Velasquez N.
        • May M.
        • et al.
        A comparative evaluation of the dopamine D2/3 agonist radiotracer [11C]NPA and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum.
        J Pharmacol Exp Ther. 2010; 63: 574-584
        • Abi-Dargham A.
        • Martinez D.
        • Mawlawi O.
        • Simpson N.
        • Hwang D.R.
        • Slifstein M.
        • et al.
        Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: Validation and reproducibility.
        J Cereb Blood Flow Metab. 2000; 20: 225-243
        • Innis R.B.
        • Cunningham V.J.
        • Delforge J.
        • Fujita M.
        • Gjedde A.
        • Gunn R.N.
        • et al.
        Consensus nomenclature for in vivo imaging of reversibly binding radioligands.
        J Cereb Blood Flow Metab. 2007; 27: 1533-1539
        • Lutz P.E.
        • Zhou Y.
        • Labbe A.
        • Mechawar N.
        • Turecki G.
        Decreased expression of nociceptin/orphanin FQ in the dorsal anterior cingulate cortex of suicides.
        Eur Neuropsychopharmacol. 2015; 25: 2008-2014
        • Lindholm S.
        • Ploj K.
        • Franck J.
        • Nylander I.
        Nociceptin/orphanin FQ tissue concentration in the rat brain. Effects of repeated ethanol administration at various post-treatment intervals.
        Prog Neuropsychopharmacol Biol Psychiatry. 2002; 26: 303-306
        • Zorrilla E.P.
        • Valdez G.R.
        • Weiss F.
        Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats.
        Psychopharmacology (Berl). 2001; 158: 374-381
        • Sommer W.H.
        • Rimondini R.
        • Hansson A.C.
        • Hipskind P.A.
        • Gehlert D.R.
        • Barr C.S.
        • et al.
        Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala Crhr1 expression following a history of dependence.
        Biol Psychiatry. 2008; 63: 139-145
        • Ciccocioppo R.
        • de Guglielmo G.
        • Hansson A.C.
        • Ubaldi M.
        • Kallupi M.
        • Cruz M.T.
        • et al.
        Restraint stress alters nociceptin/orphanin FQ and CRF systems in the rat central amygdala: Significance for anxiety-like behaviors.
        J Neurosci. 2014; 34: 363-372
        • Rodi D.
        • Zucchini S.
        • Simonato M.
        • Cifani C.
        • Massi M.
        • Polidori C.
        Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: Evidence for involvement of the bed nucleus of the stria terminalis.
        Psychopharmacology (Berl). 2008; 196: 523-531

      Linked Article